<html>
<head>
   <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
   <meta name="Content-Type" content="text/html; charset=iso-8859-1" />
   <meta name="description" content="Interactive Introductory / Foundational Evolution and Molecular Biology" />
   <meta name="keywords" content="free on-line biology text, interactive molecular biology, interactive text, biology on-line" /><meta name="" content="ffree on-line biology, molecular biology, text" />
   <meta name="keywords" content="Biofundamentals, College-level, Foundational concepts, Klymkowsky, Evolution, Molecular Biology, Cell Biology, Interactive" />
   <meta name="GENERATOR" content="Mozilla/4.75 (Macintosh; U; PPC) [Netscape]" />

<title>Biofundamentals @ UC Boulder - Regulating protein activity</title>
<script language="JavaScript" type="text/JavaScript">
<!--

function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}
//-->
</script>
<script src="../../../Biofundamentals/Scripts/AC_RunActiveContent.js" type="text/javascript"></script>
</head>
<style type="text/css">
<!--
.unnamed1 {  background-color: #FFFFFF}
.style2 {font-family: Arial, Helvetica, sans-serif}
.style3 {
	color: #990000;
	font-weight: bold;
}
body,td,th {
	font-family: Arial, Helvetica, sans-serif;
}
.style4 {color: #000000}
.style5 {font-size: x-small}
.white {
	color: #FFF;
}
-->
</style>
<body bgcolor="#FCFDFF" text="#000000" link="#0000FF" vlink="#0066FF" alink="#0066FF">
<table width="720" border="0" cellpadding="0" cellspacing="0">
    <tr>
        <td width="668"><font color="#000000" face="Arial, Helvetica, sans-serif"><b>25.
                    Regulating protein localization and activity<a name="top"></a></b></font></td>
        <td width="27"><a href="Topic3-7_Assemblying Proteins.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowLEFT.GIF" alt="arrow previous" width="24" height="24" border="0" /></a></td>
        <td width="25"><div align="right"><a href="Topic4-1_GeneExp.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowRIGHT.gif" alt="arrow" width="24" height="24" border="0" /></a></div></td>
        <table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" noshade /></td>
  </tr>
</table>
    </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
<tr>
        <td width="330"><p><img src="../../../Biofundamentals/BioFun-Support/wordles/page21.jpg" width="330" height="170" alt="page 19" /></p></td>
        <td width="15">&nbsp;</td>
        <td width="355"><p><b><font face="Arial, Helvetica, sans-serif"><span class="style4">Telling
          proteins where to go:</span></font><font face="Arial, Helvetica, sans-serif" color="#006600">&nbsp; </font></b></p>
          <p><font face="Arial, Helvetica, sans-serif">Translation
            of proteins occurs in the cytoplasm, where mature
            ribosomes are located.
            &nbsp; If no information is added, a newly synthesized polypeptide
      will remain in the cytoplasm, that is its default<b><font color="#990000"> </font></b>location. </font></p></td>
    </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><font face="Arial, Helvetica, sans-serif">Yet even in the structurally
            simplest of cells, the bacteria and archaea, there is more
            than one place that a protein may end up: it can remain in
            the cytoplasm, it can be inserted into the plasma membrane
    or it may be secreted from the cell.&nbsp;&nbsp; Both
                    membrane and secreted polypeptides must be inserted into,
    or pass through, the plasma membrane.</font></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
<tr>
        <td height="55" width="410"><p><font face="Arial, Helvetica, sans-serif">Polypeptides
                destined for the membrane or for secretion are generally
    marked by a specific tag, known as a signal                    sequence</font>. &nbsp; </p>
<p><font face="Arial, Helvetica, sans-serif">The signal sequence
                    consists of a stretch of hydrophobic amino acids, often at
                  the N-terminus of the polypeptide.&nbsp; </font></p>
            <p><font face="Arial, Helvetica, sans-serif">As the signal sequence
                    emerges from the ribosome it interacts with a signal
                    recognition particle</font> or SRP -
    a complex of polypeptides and a structural RNA. </p>
            <p><font face="Arial, Helvetica, sans-serif">The binding of SRP to
the signal sequence causes translation to pause. </font> SRP acts as a chaperone for membrane proteins.</p></td>
        <td height="55" width="10">&nbsp;</td>
        <td height="55" width="300"><p>
            <iframe width="320" height="240" src="http://www.youtube.com/embed/JCPPlJfrP4k?rel=0" frameborder="0" allowfullscreen></iframe>
    </p></td>
    </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
        <td>&nbsp;</td>
    </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
    <tr>
        <td><p><font face="Arial, Helvetica, sans-serif">The mRNA/ribosome/nascent
                    polypeptide/SRP complex will find (by diffusion), and attach
                    to, a ribosome/SRP receptor</font> complex
                    on the cytoplasmic surface of the plasma membrane (in bacteria
              and archaea.) </p>
            <p><font face="Arial, Helvetica, sans-serif">This ribosome/SRP receptor
                    is associated with a polypeptide
                    pore</font>. When the ribosome/SRP complex docks
                    with the receptor, translation resumes and the nascent polypeptide
    passes through a protein pore and so through the membrane. </p>
            <p><font face="Arial, Helvetica, sans-serif">As the polypeptide emerges
                    on the extracytoplasmic side of the membrane, the signal
                    sequence is generally removed by an enzyme, signal
      sequence peptidase</font>. </p>
      <p><font face="Arial, Helvetica, sans-serif">If the polypeptide is
                    a membrane protein, it will remain within the membrane. If
                    it is a secreted polypeptide, it will be released into the
      periplasmic space. </font></p></td>
    </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
    <tr>
        <td><p><font face="Arial, Helvetica, sans-serif">Eukaryotic cells are
                structurally and topologically more complex than bacterial and
                    archaeal cells; there are  more places for a newly synthesized
                    protein to end up.&nbsp; </font></p>
<p><font face="Arial, Helvetica, sans-serif">While we will not discuss
                    the details of that process, one rule of thumb is worth keeping
                  in mind.&nbsp; </font></p>
            <p><font face="Arial, Helvetica, sans-serif">Generally, in the absence
                    of added information, a newly synthesized polypeptide will
        end up in the cytoplasm. </font></p></td>
        <td>&nbsp;</td>
        <td><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/CellCompartments.jpg" alt="" width="360" height="324" /></td>
    </tr>
</table>
<table width="720" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">As in bacteria
      and archaea, polypeptides destined for secretion or insertion
      into internal membrane systems (that is the endoplasmic reticulum)
      are directed to their final location by the signal
      sequence/SRP</font> system. </p>
      <p><font face="Arial, Helvetica, sans-serif">Proteins that must function
        in the nucleus generally get there because they have a nuclear
        localization sequence or NLS.&nbsp;&nbsp; </font></p>
      <p><font face="Arial, Helvetica, sans-serif">On the other hand, proteins
        can be excluded from the nucleus using a nuclear
        exclusion sequence or NES. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">Likewise, other localization
        signals and sequences are used to direct proteins to other
    intracellular compartments.</font></p></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" noshade></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr> 
    <td width="512"> 
      <div align="left"> 
        <p><font face="Arial, Helvetica, sans-serif"><strong>Regulating protein activity:</strong></font></p>
        <p><font face="Arial, Helvetica, sans-serif">Proteins
            act through their interactions with other molecules.&nbsp; Enzymes interact with substrate molecules; these interactions lower the activation
            energy of the reaction's rate limiting step, leading 
            to an increase in the overall reaction rate.&nbsp;</font></p>
        <p><font face="Arial, Helvetica, sans-serif">At the same time, cells
            and organisms are not static.&nbsp; They must  regulate
            protein activity to adapt to changes in their environment or 
            within the organism.&nbsp;</font></p>
        <p><font face="Arial, Helvetica, sans-serif">A protein's activity can
          be regulated in a number of ways. The
      first and most obvious is to control the total number of protein molecules
      present within the system.&nbsp;&nbsp; </font></p>
        <p><font face="Arial, Helvetica, sans-serif">Let us assume that once synthesized,
          a protein is fully active. With this simplifying assumption,
          the total concentration 
          protein in a system  [P<sub>sys</sub>] is proportional to </font></p>
        <p align="center"><font face="Arial, Helvetica, sans-serif"> (the rate of protein synthesis) minus (the rate of protein degradation).&nbsp; </font></p>
        <p><font face="Arial, Helvetica, sans-serif"><strong>What
          controls the rate of protein synthesis?</strong>&nbsp; Clearly this
          is primarily a function of the number of mRNAs encoding the protein
          present in the cell.&nbsp;</font><font face="Arial, Helvetica, sans-serif">It
            is generally the case that once translation begins, it continues
            at a more or less constant rate.&nbsp;</font></p>
      </div>
    </td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="494"><p><font face="Arial, Helvetica, sans-serif">In the bacterium <em>E.
                    coli</em>, the rate of translation at 37&ordm;C is about <a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=stryer.section.4125" target="_blank">15
                    amino acids per second</a>.&nbsp; The translation of a polypeptide
                    of 1500 amino acids therefore takes about 100 seconds.&nbsp;</font></p>
        <p><font face="Arial, Helvetica, sans-serif">After
            translation, folding and, in multisubunit proteins, assembly, </font><font face="Arial, Helvetica, sans-serif"> the
                protein will function until it is degraded.&nbsp; </font></p>
      <p><font face="Arial, Helvetica, sans-serif">Protein
                degradation often begins when the protein 
          is specifically marked for degradation.&nbsp;</font><font face="Arial, Helvetica, sans-serif">This is an active process,
          involving ATP hydrolysis and a multisubunit complex known as the proteosome (see
          previous page).</font></p>
<p><font face="Arial, Helvetica, sans-serif">The proteosome degrades the
    polypeptide into small peptides and amino acids, that can be recycled. </font> Degradation has a drawback, however, it is irreversible. </p>
    </td>
    <td width="10">&nbsp;</td>
    <td width="217"><div align="right"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/Goodsell_Proteosomejpg.jpg" width="216" height="270" border="0" /></div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">A
          second and reversible form of regulation is known as allosteric</font> regulation. <font face="Arial, Helvetica, sans-serif">In
          allosteric regulation, regulatory molecules bind reversibly to the
          protein, altering its confirmation, which in turn alters the protein's
          activity.&nbsp;&nbsp;</font><font face="Arial, Helvetica, sans-serif">Such
        allosteric effectors are not covalently attached to the protein.</font></p>
      <p><font face="Arial, Helvetica, sans-serif">Here, the activity
      of a protein is positively regulated by the binding of a factor. </font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr> 
    <td width="358"><p><font face="Arial, Helvetica, sans-serif">This factor could be a small
          molecule or another protein. </font></p>
<p><font face="Arial, Helvetica, sans-serif">What is important is that
        the allosteric binding site is distinct from the enzyme's catalytic site. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">That is what allosteric means, other site.</font></p>
      <p><font face="Arial, Helvetica, sans-serif">An allosteric
      effector can also act negatively, inhibiting an enzyme's activity.</font></p>
      <p><font face="Arial, Helvetica, sans-serif">Because allosteric regulators
        do not bind to the same site on the protein as the substrate, changing
      substrate concentration generally does not alter their effects.</font></p></td>
    <td width="12" bgcolor="#FFFFFF">&nbsp;</td>
    <td width="350"><iframe width="400" height="300" src="http://www.youtube.com/embed/d5fDEUhjo-M?rel=0" frameborder="0" allowfullscreen></iframe></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr> 
    <td>&nbsp; </td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr> 
    <td> <p><font face="Arial, Helvetica, sans-serif">Of course there are other types 
      of regulation as well.  
    </font></p>
      <p><font face="Arial, Helvetica, sans-serif"><strong>Active site
        inhibitors</strong>:
        An inhibitory factor may bind to and block the active site. </font></p>
<p><font face="Arial, Helvetica, sans-serif">If this binding is reversible,
           then increasing the amount of substrate can over-come the inhibition. 
        An inhibitor of this type is known as a competitive</font> 
      inhibitor.  </p>
      <p><font face="Arial, Helvetica, sans-serif">In some cases, the inhibitor
           chemically reacts with the enzyme, forming a covalent bond.&nbsp;</font><font face="Arial, Helvetica, sans-serif">Because
           this type of inhibitor is essentially irreversible, increasing substrate
          concentration does not overcome inhibition. These are therefore known
          as non-competitive</font> inhibitors.&nbsp;</p>
      <p><font face="Arial, Helvetica, sans-serif">Allosteric effectors are also
               non-competitive, since they do not compete with substrate for
              binding  to the active site.</font> That said, binding of substrate
              could, in theory, change the affinity of the protein for allosteric
              effectors, just as binding of the allosteric effector changes the
              binding affinity of the protein for the substrate. </p>
    </td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><strong><font face="Arial, Helvetica, sans-serif">Post-translational
            regulation: </font></strong></p>
        <p><font face="Arial, Helvetica, sans-serif">P</font><font face="Arial, Helvetica, sans-serif">roteins
            may be modified after synthesis &ndash; this process  is known as post-translational
                modification</font>.&nbsp;&nbsp;<font face="Arial, Helvetica, sans-serif">A
                    number of post-translational
      modifications have been found to occur within  cells.&nbsp; </font></p>
      <p><font face="Arial, Helvetica, sans-serif">The first type 
              involve the covalent addition of specific groups to specific sites
              on the protein 
          &ndash; these groups can range from phosphate groups
              (phosphorylation), an acetate group
              (acetylation), the attachment of lipid/hydrophobic
              groups (lipid
      modification), or carbohydrates (glycosylation).&nbsp; </font></p>
      <p><font face="Arial, Helvetica, sans-serif">Many</font><font face="Arial, Helvetica, sans-serif"> post-translational
          modifications are reversible,
          one enzyme adds the modifying group, and another can act to remove
          it.&nbsp; </font><font face="Arial, Helvetica, sans-serif">For
            example, proteins are phosphorylated by  enzymes known as protein</font> kinases,
            while protein
      phosphatases remove phosphate groups.&nbsp; </p>
      <p><font face="Arial, Helvetica, sans-serif">Post-translational 
          modifications  act in much the same way as do  allosteric
          effectors, they modify the structure and, in turn, the activity of the polypeptide to which they
          are attached.&nbsp;</font><font face="Arial, Helvetica, sans-serif">They
          can also modify a proteins interactions with other proteins, the protein's
          localization within&nbsp; the
          cell, or its stability.&nbsp; </font></p>
      </td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="205"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/trypsinogen.gif" width="205" height="247" /></td>
    <td width="10">&nbsp;</td>
    <td width="485"><p><strong>Proteolytic processing:</strong>&nbsp; Another
         method for regulating protein activity involves
        the cleavage of the polypeptide chain.&nbsp;  </p>
      <p>Many proteins are originally synthesized in a longer, and inactive &quot;pro-form&quot;.&nbsp;&nbsp; </p>
      <p>To
          become active the pro-peptide must be removed &ndash; it
          is cut by a protease.&nbsp; </p>
      <p>This proteolytic processing activates the protein.&nbsp;  Proteolytic
      processing is itself often  regulated.&nbsp; </p></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
    <tr>
    <td><hr size="1" noshade /></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0" bgcolor="#CCCCCC">
  <tr>
    <td width="80" bgcolor="#990000"><div align="center">
      <p class="white">Questions to answer</p>
      <p class="white">&nbsp;</p>
      <p class="white"><br />
      </p>
    </div></td>
    <td width="640" bgcolor="#FFFFFF"><font face="Arial, Helvetica, sans-serif">&nbsp; </font>
      <ol>
        <li>A protein binds an allosteric regulator - what happens
          to the protein?</li>
        <li>How is the post-translational
          modification of a protein like allosteric regulation?&nbsp; how
          is it different?</li>
        <li>Why are enzymes required for post-translational modification? </li>
        <li>Why is a negative allosteric regulator not considered a &quot;competitive&quot; inhibitor?&nbsp;</li>
        <li>Why do post-translational modifications (and their reversals)  require energy?</li>
        <li>How does a   signal sequence influence  translation?&nbsp;&nbsp;</li>
        <li>How would a cell recover from the effects of an irreversible, non-competitive
          inhibitor? </li>
        <li><span class="style21">Why might a cell want a specific protein to
          have a short half-life? </span></li>
      </ol></td>
  </tr>
  <tr>
    <td bgcolor="#0000FF"><div align="center"><span class="whoe1"><span class="white">Questions to ponder</span></span><br />
    </div></td>
    <td bgcolor="#FFFFFF"><ul>
      <li class="style21"><span class="style2">A cell is starved for amino acids - what will happen
        to  protein synthesis rate and why?</span></li>
      <li class="style21"><span class="style2">What would happen if you somehow put a signaling sequence
        at the beginning of a normally cytoplasmic polypeptide?</span></li>
    </ul></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" noshade /></td>
  </tr>
</table>
<table width="720" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="405"><p><strong>
      <iframe width="720" height="570" frameborder="0" src="http://besocratic.clemson.edu/besocratic.html?Activity=862#/ActivityViewerPage"></iframe>
    </strong></p></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
    <tr>
    <td><hr size="1" /></td>
  </tr>
</table>
<table width="720" border="0" cellspacing="0" cellpadding="0">
  <tr>
      <td width="29"><a href="Topic3-7_Assemblying Proteins.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowLEFT.GIF" alt="arrow previous" width="24" height="24" border="0" /></a></td>
    <td width="29"><a href="#TOP"><font face="Arial, Helvetica, sans-serif" size="-2"> <img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowUP.GIF" alt="arrow" width="24" height="24" /></font></a></td>
    <td width="646"><div align="right">
        <!-- #BeginDate format:En2 -->31-Aug-2012<!-- #EndDate -->
    </div></td>
    <td width="25"><div align="right"><a href="Topic4-1_GeneExp.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowRIGHT.gif" alt="arrow next" width="24" height="24" border="0" /></a></div></td>
  </tr>
</table>

<script type='text/javascript'>var _hl=_hl||{};_hl.site='41';(function(){var hl=document.createElement('script');hl.type='text/javascript';hl.async=true;hl.src=document.location.protocol+'//highlighter.com/webscript/v1/js/highlighter.js';var s=document.getElementsByTagName('script')[0];s.parentNode.insertBefore(hl,s);})();</script>
</body>
</html>

